Lookout for Severe Joint Pain with Gliptins
A new FDA warning will spur questions about whether gliptins (sitagliptin, saxagliptin, etc) cause severe joint pain.
This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling and lead to hospitalization.
We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4)...an enzyme that breaks down incretin hormones.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals